Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2732854 | 0.89 | TSHR (0.45) | TSHRALDH1A1HTTLMNAABCC4 | |
| SCHEMBL20955857 | 0.83 | ALDH1A1 (0.35) | TSHRALDH1A1HTT | |
| SCHEMBL20955858 | 0.83 | ALDH1A1 (0.35) | TSHRALDH1A1HTT | |
| SCHEMBL7252450 | 0.80 | ALDH1A1 (0.39) | TSHRALDH1A1HTT | |
| SCHEMBL1716936 | 0.80 | ALDH1A1 (0.39) | TSHRALDH1A1HTT | |
| SCHEMBL16823397 | 0.80 | ALDH1A1 (0.39) | TSHRALDH1A1HTTHIF1AABCC4 | |
| SCHEMBL4616913 | 0.80 | ALDH1A1 (0.39) | TSHRALDH1A1HTT | |
| Hydrochloric Acid SCHEMBL11351345 | 0.78 | ALDH1A1 (0.38) | TSHRALDH1A1HTTHIF1AABCC4 | |
| Hydrochloric Acid SCHEMBL11876600 | 0.78 | ALDH1A1 (0.38) | TSHRALDH1A1HTT | |
| SCHEMBL176385 | 0.76 | ALDH1A1 (0.35) | TSHRALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089452-B8 | PROCESS FOR OBTAINING INCREASED MOLECULAR WEIGHT OF A POLYMER AND THE USE OF SAID POLYMER | PERSTORP SPECIALTY CHEM AB (SE) | 2012-09-26 | — | — | EP | claimed |
| EP-2089452-B1 | PROCESS FOR OBTAINING INCREASED MOLECULAR WEIGHT OF A POLYMER AND THE USE OF SAID POLYMER | PERSTORP SPECIALTY CHEM AB (SE) | 2012-07-11 | — | — | EP | claimed |
| EP-2089452-A1 | PROCESS FOR OBTAINING INCREASED MOLECULAR WEIGHT OF A POLYMER AND THE USE OF SAID POLYMER | Perstorp Specialty Chemicals AB (SE) | 2009-08-19 | — | — | EP | claimed |
| US-20090069527-A1 | AIR DRYING POLYMER | PERSTORP SPECIALTY CHEMICALS (AB) (SE) | 2009-03-12 | — | — | US | claimed |
| WO-2008069725-A1 | PROCESS FOR OBTAINING INCREASED MOLECULAR WEIGHT OF A POLYMER AND THE USE OF SAID POLYMER | PERSTORP SPECIALTY CHEMICALS AB (SE) | 2008-06-12 | — | — | WO | claimed |
| EP-1869101-A1 | AIR DRYING POLYMER | Perstorp Specialty Chemicals AB (SE) | 2007-12-26 | — | — | EP | claimed |
| WO-2006118532-A1 | HYBRID RADIATION CURABLE COMPOSITION AND USE THEREOF | PERSTORP SPECIALTY CHEMICALS AB (SE) | 2006-11-09 | — | — | WO | claimed |
| WO-2006110075-A1 | AIR DRYING POLYMER | PERSTORP SPECIALTY CHEMICALS AB (SE) | 2006-10-19 | — | — | WO | claimed |
| EP-2560976-B9 | FUROPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2017-06-07 | — | — | EP | disclosed |
| EP-2560976-B9 | FUROPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2017-06-07 | — | — | EP | disclosed |
| EP-2560976-B1 | FUROPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2016-08-24 | — | — | EP | disclosed |
| EP-2560976-B1 | FUROPYRIDINE COMPOUNDS AND USES THEREOF | NOVARTIS AG (CH) | 2016-08-24 | — | — | EP | disclosed |
| US-9249275-B2 | Polyionic dendrimer and hydrogel comprising same | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2016-02-02 | — | — | US | disclosed |
| US-20140221292-A1 | POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2014-08-07 | — | — | US | disclosed |
| EP-0772642-A1 | STRONG CARBOXYLIC ACID FUNCTIONAL POLYURETHANE POLYMERS AND BLENDS THEREOF USED IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-05-14 | — | — | EP | disclosed |
| US-5512651-A | POLYESTERURETHANE COPOLYMER | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-04-30 | — | — | US | disclosed |
| US-5498685-A | REACTION WITH POLAR-FUNCTIONAL DICARBOXYLIC ACID ANHYDRIDES | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-03-12 | — | — | US | disclosed |
| WO-1996004326-A1 | STRONG CARBOXYLIC ACID FUNCTIONAL POLYURETHANE POLYMERS AND BLENDS THEREOF USED IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-02-15 | — | — | WO | disclosed |
| EP-0696295-A1 | CARBOXYLIC-ACID FUNCTIONAL POLYURETHANE POLYMERS AND THEIR USE IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-02-14 | — | — | EP | disclosed |
| WO-1994025500-A1 | CARBOXYLIC-ACID FUNCTIONAL POLYURETHANE POLYMERS AND THEIR USE IN MAGNETIC RECORDING MEDIA | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140221292-A1 | POLYIONIC DENDRIMER AND HYDROGEL COMPRISING SAME | CD44, PCNA, GMNN | TSHR 999/4885ALDH1A1 2155/4885HTT 1167/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.